Supraflex Cruz Sirolimus-eluting Stent

DEVICE2 trials

Sponsors

Sahajanand Medical Technologies Limited, Fundación EPIC

Conditions

Coronary Artery DiseaseIschemic Heart Disease

Unknown Phase

Cruz HBR Registry - Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Stent

CompletedNCT04138238

Sahajanand Medical Technologies LimitedCoronary Artery Disease

Start: 2020-02-19End: 2022-05-31Updated: 2023-07-12

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

RecruitingNCT06863155

Fundación EPICCoronary Artery Disease, Ischemic Heart Disease

Start: 2025-05-06End: 2029-03-31Target: 500Updated: 2026-08-06